N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide

C27H53F2N7O2 — CID 163567721

IUPACN-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide
SMILESCCCC(CC)CCC(F)CNC(C)C(C(=O)NC1CNCC(F)C1N1CCN2CCOC[C@H]2C1)C(N)N
InChIInChI=1S/C27H53F2N7O2/c1-4-6-19(5-2)7-8-20(28)13-33-18(3)24(26(30)31)27(37)34-23-15-32-14-22(29)25(23)36-10-9-35-11-12-38-17-21(35)16-36/h18-26,32-33H,4-17,30-31H2,1-3H3,(H,34,37)/t18?,19?,20?,21-,22?,23?,24?,25?/m1/s1
InChIKeyFWQAIHAHDXBXNN-HZOPGPIWSA-N
MW545.76 g/mol
LogP0.58
Rot. Bonds14

About N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide

N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide (PubChem CID 163567721) has the molecular formula C27H53F2N7O2 and a molecular weight of 545.76 g/mol. Its IUPAC name is N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide.

Molecular Properties

Compound NameN-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide
PubChem CID163567721
Molecular FormulaC27H53F2N7O2
Molecular Weight545.76 g/mol
Exact Mass545.42
IUPAC NameN-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide
SMILESCCCC(CC)CCC(F)CNC(C)C(C(=O)NC1CNCC(F)C1N1CCN2CCOC[C@H]2C1)C(N)N
InChIInChI=1S/C27H53F2N7O2/c1-4-6-19(5-2)7-8-20(28)13-33-18(3)24(26(30)31)27(37)34-23-15-32-14-22(29)25(23)36-10-9-35-11-12-38-17-21(35)16-36/h18-26,32-33H,4-17,30-31H2,1-3H3,(H,34,37)/t18?,19?,20?,21-,22?,23?,24?,25?/m1/s1
InChIKeyFWQAIHAHDXBXNN-HZOPGPIWSA-N
XLogP0.58
TPSA120.91 Ų
H-Bond Donors5
H-Bond Acceptors8
Rotatable Bonds14
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500545.76
LogP ≤ 50.58
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide?
The IUPAC name of N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide (CID 163567721) is N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide.
What is the SMILES notation for N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide?
The canonical SMILES for N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide is CCCC(CC)CCC(F)CNC(C)C(C(=O)NC1CNCC(F)C1N1CCN2CCOC[C@H]2C1)C(N)N.
What is the InChIKey of N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide?
The InChIKey is FWQAIHAHDXBXNN-HZOPGPIWSA-N. The full InChI is InChI=1S/C27H53F2N7O2/c1-4-6-19(5-2)7-8-20(28)13-33-18(3)24(26(30)31)27(37)34-23-15-32-14-22(29)25(23)36-10-9-35-11-12-38-17-21(35)16-36/h18-26,32-33H,4-17,30-31H2,1-3H3,(H,34,37)/t18?,19?,20?,21-,22?,23?,24?,25?/m1/s1.
What are the key properties of N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide?
N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide has a molecular weight of 545.76 g/mol, XLogP of 0.58, 14 rotatable bonds, 5 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[(9aR)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoropiperidin-3-yl]-2-(diaminomethyl)-3-[(5-ethyl-2-fluorooctyl)amino]butanamide is sourced from PubChem (CID 163567721), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).